1. Home
  2. SEM vs PHVS Comparison

SEM vs PHVS Comparison

Compare SEM & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Select Medical Holdings Corporation

SEM

Select Medical Holdings Corporation

HOLD

Current Price

$16.46

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Pharvaris N.V.

PHVS

Pharvaris N.V.

HOLD

Current Price

$28.53

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEM
PHVS
Founded
1996
2015
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
SEM
PHVS
Price
$16.46
$28.53
Analyst Decision
Buy
Buy
Analyst Count
4
11
Target Price
$15.17
$41.82
AVG Volume (30 Days)
1.3M
207.3K
Earning Date
04-30-2026
05-12-2026
Dividend Yield
1.52%
N/A
EPS Growth
N/A
N/A
EPS
1.16
N/A
Revenue
N/A
N/A
Revenue This Year
$5.45
N/A
Revenue Next Year
$4.78
N/A
P/E Ratio
$14.19
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.65
$15.51
52 Week High
$18.61
$30.24

Technical Indicators

Market Signals
Indicator
SEM
PHVS
Relative Strength Index (RSI) 71.43 53.12
Support Level $16.20 $24.55
Resistance Level $16.59 $29.82
Average True Range (ATR) 0.04 1.40
MACD -0.01 -0.03
Stochastic Oscillator 89.29 60.80

Price Performance

Historical Comparison
SEM
PHVS

About SEM Select Medical Holdings Corporation

Select Medical Holdings Corp is a healthcare company that operates through three segments: critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. Critical illness recovery hospitals which derives maximum revenue consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. Patients are typically admitted to critical illness recovery hospitals and rehabilitation hospitals from general acute care hospitals. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services.

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

Share on Social Networks: